Nijmegen

• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthritis Pending
  2025-520710-58-00 6 Diagnosis of RA according to the ACR/EULAR 2010 criteria without a his
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti … Pending
  2025-521038-27-00 5 Immune system diseases
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Research into the effect of Obinutuzumab on the level of PLA2R antibodies in patients with membranous nephropathy. Pending
  2025-521139-35-01 4 Primary membranous nephropathy
• Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Pending
  2025-521533-85-00 7 Ventilator-Associated Pneumonia
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending
  2025-521590-13-00 5 Moderately to Severely Active Crohn’s Disease
• The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending
  2025-521770-34-00 3 Chronic pulmonary aspergillosis
• A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria … Pending
  2025-521983-36-00 4 Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenoc
• A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps Pending
  2025-522045-21-00 1 Melanoma
• REVITALISE Study Pending
  2025-522060-32-00 4 STEMI (ST elevated Myocardial Infarction)
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Pending
  2025-522118-21-00 6 Acute Anterior Uveitis
• A trial to compare treatment with surlorian (ARM210, S48168) to placebo in effects on muscle strength and safety in adults with autosomal do … Pending
  2025-522343-18-00 4 Autosomal Dominant RYR1-Related Myopathy
• An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease Pending
  2025-522460-33-00 5 Stargardt Disease
• A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative co … Pending
  2025-522511-42-00 4 Crohn's disease
• Inhaled corticosteroids in young children with episodic wheezing: a multicenter cluster RCT Pending
  2025-522694-11-00 6 Episodic expiratory wheezing
• MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Pending
  2025-522710-22-00 6 Cancer, bone metastasis, pain
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending
  2025-522855-25-00 5 Carcinoma, Transitional Cell
• PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Pending
  2025-522883-34-00 6 Metastatic cervical cancer
• Efficacy, Safety, and Tolerability of DYNE-101 in Participants with Myotonic Dystrophy Type 1 Pending
  2025-522957-20-00 5 Myotonic Dystrophy Type 1
• SHIELD – Swift Hydrocortisone Intervention after trauma exposure Pending
  2025-523350-13-02 4 Posttraumatic Stress Disorder (PTSD)
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis

Showing 25–48 of 568 trials